Along the same vein, squamous cell carcinoma lines engineered to express constitutively active AKT display down-regulation of E-cadherin, reduced cell–cell adhesion and increased motility in vivo (Grille et al., 2003). The gene discussed is AKT1; the disease is squamous cell carcinoma.